Natera, Inc. (NTRA) Financial Statements (2025 and earlier)

Company Profile

Business Address 13011 MCCALLEN PASS
AUSTIN, TX 78753
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments22,689236,882898,306914,282737,274440,991
Cash and cash equivalent   466,00584,38648,66861,926
Short-term investments22,689236,882432,301829,896688,606379,065
Restricted cash and investments   8622818755
Receivables314,165278,289244,385122,07478,56553,351
Inventory, net of allowances, customer advances and progress billings44,74440,75935,40626,90920,03112,394
Inventory44,74440,75935,40626,90920,03112,394
Other undisclosed current assets994,222702,61933,63429,64526,60616,376
Total current assets:1,375,8201,258,5491,211,8171,093,138862,663523,167
Noncurrent Assets
Operating lease, right-of-use asset86,14956,53771,87459,01321,39923,730
Property, plant and equipment162,046111,21092,45365,51633,34823,283
Other noncurrent assets36,72015,40318,33018,82014,74312,476
Total noncurrent assets:284,915183,150182,657143,34969,49059,489
TOTAL ASSETS:1,660,7351,441,6991,394,4741,236,487932,153582,656
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities97,03660,85575,15868,14798,87473,735
Employee-related liabilities44,01040,94130,37116,088
Accounts payable34,92214,99831,14827,2068,0968,604
Accrued liabilities62,11445,857  60,40749,043
Deferred revenue19,75416,61210,7777,40450,12556,016
Debt80,36280,40280,35050,05250,05450,123
Other liabilities146,893149,405144,21493,353  
Total current liabilities:344,045307,274310,499218,956199,053179,874
Noncurrent Liabilities
Long-term debt and lease obligation  282,945281,653341,430223,73999,953
Long-term debt, excluding current maturities  282,945281,653280,394202,49373,656
Liabilities, other than long-term debt113,42686,15396,57822,79723,12524,118
Deferred revenue16,83819,12820,00121,31822,80523,808
Other liabilities    1,479320310
Operating lease, liability96,58867,02576,57761,03621,24626,297
Other undisclosed noncurrent liabilities7,844     
Total noncurrent liabilities:121,270369,098378,231364,227246,864124,071
Total liabilities:465,315676,372688,730583,183445,917303,945
Equity
Equity, attributable to parent1,195,420765,327705,744653,304486,236278,711
Common stock1211111098
Additional paid in capital3,763,6143,145,8372,664,7302,050,4171,411,286976,955
Accumulated other comprehensive income (loss)(344)(3,085)(16,362)(2,287)4,259919
Accumulated deficit(2,567,862)(2,377,436)(1,942,635)(1,394,836)(929,318)(699,171)
Total equity:1,195,420765,327705,744653,304486,236278,711
TOTAL LIABILITIES AND EQUITY:1,660,7351,441,6991,394,4741,236,487932,153582,656

Income Statement (P&L) ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues1,696,9111,082,571820,222625,486391,005302,328
Cost of revenue(672,474)(587,186)(412,586)(276,274)(202,266)(171,458)
Gross profit:1,024,437495,385407,636349,212188,739130,870
Operating expenses(1,246,731)(941,630)(948,676)(817,386)(405,016)(247,157)
Operating loss:(222,294)(446,245)(541,040)(468,174)(216,277)(116,287)
Interest and debt expense(10,685)(12,638)(9,319)(8,305)(20,930)(10,693)
Loss from continuing operations before equity method investments, income taxes:(232,979)(458,883)(550,359)(476,479)(237,207)(126,980)
Other undisclosed income from continuing operations before income taxes43,24824,3533,5385,3817,5624,152
Loss from continuing operations before income taxes:(189,731)(434,530)(546,821)(471,098)(229,645)(122,828)
Income tax expense (benefit)(695)(271)(978)(618)(98)(1,999)
Loss from continuing operations:(190,426)(434,801)(547,799)(471,716)(229,743)(124,827)
Loss before gain (loss) on sale of properties:(471,716)(229,743)(124,827)
Net loss available to common stockholders, diluted:(190,426)(434,801)(547,799)(471,716)(229,743)(124,827)

Comprehensive Income ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(190,426)(434,801)(547,799)(471,716)(229,743)(124,827)
Comprehensive loss:(190,426)(434,801)(547,799)(471,716)(229,743)(124,827)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2,74113,277(14,075)(6,546)3,3401,471
Comprehensive loss, net of tax, attributable to parent:(187,685)(421,524)(561,874)(478,262)(226,403)(123,356)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: